Fast Track Designation highlights potential of ATH434 to address high unmet need for individuals with MSA – MELBOURNE, Australia and SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Alterity ...

Researchers at the University of Oklahoma have made a breakthrough discovery that could potentially revolutionize treatments ...

REMSEN, Iowa, April 10, 2025 /PRNewswire/ -- If you are looking for the latest treatment for depression without medication, pain, or downtime, Modified Wellness Center in Remsen is the first ...

SMi Group has announced that Pavel Farkas, Senior Director for Biopharmaceutics Clinical Development at PLIVA, will be joining the speaker line-up for the 15th annual Controlled Release Delivery ...

Dosage for Jakafi (ruxolitinib) may vary based on the condition it’s being used to treat. You’ll typically take this drug twice per day. Your doctor may adjust your dosage based on certain ...

The biotech’s drug, Imcivree, has FDA approvals for two rare forms of obesity. Preliminary data from a pivotal test in yet another type position the drug to continue Rhythm’s pipeline-in-a ...

Pharmaceutical companies are responding with innovative formulations and dosage forms of iodine supplements tailored to different patient demographics and regional needs. This driver underscores the ...